• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Up and Coming

Up and Coming

September 9, 2019

This feature highlights changes in clinical research organizations’ personnel.

Accent Therapeutics

Accent Therapeutics has appointed Shakti Narayan chief executive officer. Narayan was most recently chief business officer at Tango Therapeutics.

Aprecia

Kimberly Bone was named vice president of the medical and clinical affairs division at Aprecia. Bone previously spent 13 years working for Publix Super Markets where she served as clinical pharmacist, retail pharmacy manager and manager of managed care.

Aristea Therapeutics

Nihar Bhakta has been named chief medical officer at Aristea Therapeutics. Bhakta was previously project team leader at Gossamer Bio.

Bayer

Marianne De Backer has been named head of business development & licensing of the pharmaceuticals division at Bayer. De Backer previously led business development activities across different therapeutic areas and geographies at Johnson & Johnson.

Beam Therapeutics

Beam Therapeutics has named Terry-Ann Burrell as chief financial officer. Burrell was most recently at J.P. Morgan, where she was a managing director in the healthcare investment banking group.

BioMatrix Specialty Pharmacy

BioMatrix Specialty Pharmacy has appointed Nick Karalis chief executive officer. Karalis was the chief operating officer of BioMatrix Specialty Pharmacy, and founder of Elwyn Pharmacy group that became part of BioMatrix in 2017.

Bolt

Randall Schatzman has been named chief executive officer at Bolt Therapeutics, Inc. Schatzman most recently served as president and CEO of Alder BioPharmaceuticals, Inc.

Cardinal Analytx Solutions

Cardinal Analytx Solutions has named Ryan Tarzy chief commercial officer. Previously, Tarzy served as the head of strategy and business at CoverMyMeds.

Cook Medical

Cook Medical has appointed Rose Kelly-Falls global leader of procurement and supply chain. Previously, Kelly-Falls was vice president of sourcing and customer engagement at Proxima Group.

Dynacure

David Garrett has been named chief financial officer at Dynacure. Garrett was most recently vice president, corporate controller and head of investor relations at Nabriva Therapeutics, Inc.

Genfit

Genfit has appointed Pascal Prigent as chief executive officer. Previously, Prigent served as the executive vice president of marketing and commercial development at Genfit.

Genor Biopharma

Jack Hu has been named chief financial officer and chief strategy officer of Genor Biopharma. Hu’s most recently appointment was with Deutsche Bank, where he was head of APAC healthcare research.

Harmonic Bionics

Harmonic Bionics has appointed Christopher Prentice chief executive officer of Austin, Texas-based Harmonic Bionics. Prentice previously served as head of commercial integration at Medtronic.

Invicro

Invicro, a Konica Minolta company, named Hidenori Seshimo vice president of biomarker services for Japan. Seshimo most recently served as representative director and regional vice president of business development for Bioclinica Japan K.K.

Kadmom
Kadmom has announced that Gregory Moss has been named executive vice president and chief compliance officer. Previously, Moss served as senior vice president at Kadmom.

Kayentis

Kayentis has appointed Estelle Haenel as medical director in France. Previously, Haenel served as the clinical pharmacology early development strategy lead.

Locate Bio

Locate Bio has named John von Benecke chief financial officer and chief operating officer. Previously, Benecke served as the chief financial officer at Creavo Medical Technologies and Veryan Medical.

Macrophage Pharma

Søren Bregenholt has been named chief executive officer at Macrophage Pharma Limited. Bregenholt previously served as chief operating officer at Symphogen.

MODAG

Johannes Levin has been appointed chief medical officer at MODAG. Levin is a group leader in the Neurodegenerative Diseases Group of the Department of Neurology of the Ludwig Maximilian University of Munich and at the German Center for Neurodegenerative Diseases.

Orbis International

Orbis International has named Danusia Dzierzbinski chief financial officer. Dzierzbinski most recently served as the deputy chief financial officer at the International Rescue Committee.

OMEICOS Therapeutics

OMEICOS Therapeutics has appointed Simon Russell as chief business officer. Russell most recently co-founded Synendos Therapeutics.

 

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing